Clarity Pharmaceuticals Ltd.ASX: CU6

Clarity receives $3.26 million R&D tax incentive refund

Feb 4, 2022 at 4:16 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment